cell
ms
pathogenesi
outlin
basic
concept
tcell
immunolog
summar
current
understand
role
tcell
pathogenesi
ms
lymphocyt
play
central
role
pathogenesi
multipl
sclerosi
ms
zhan
g
et
al
cell
demon
strate
ms
lesion
cell
predom
inat
acu
te
lesion
cd
cell
obser
ved
frequen
tli
chronic
lesion
rain
additiona
lli
cell
found
four
describ
histopatholog
subtyp
ms
lucchinetti
et
al
activ
myelinreact
cell
present
blood
cerebrospin
fluid
csf
ms
patient
contrast
nonactiv
myelinreact
cell
prese
nt
blood
control
zhan
g
et
al
succ
sever
tcelltarget
therapi
ms
reinforc
import
role
antigen
cytoplasm
tail
protein
contain
one
copi
sequenc
motif
import
signal
function
call
immunoreceptor
tyrosinebas
activ
motif
itam
phosphoryl
itam
initi
intracellular
signal
event
interact
mhcpeptid
complex
cell
necessari
insuyci
tcell
activ
addit
class
molecul
involv
tcell
antigen
recognit
activ
intracellular
signal
adhes
trayck
cell
target
organ
two
signal
requir
lymphocyt
activ
accord
twosign
model
bretscher
cohn
signal
consist
interact
tcr
antigen
present
mhc
surfac
apc
signal
consist
engag
costimulatori
receptor
tcell
ligand
present
surfac
apc
alegr
et
al
bretscher
contact
specif
antigenmhc
complex
adequ
costimulatori
signal
cell
begin
prolifer
diverenti
deliv
seri
signal
enabl
evector
function
cell
b
cell
nk
cell
cell
therebi
orchestr
immun
respons
costimulatori
molecul
may
deliv
either
stimulatori
posit
inhibitori
neg
signal
tcell
activ
brunet
et
al
exampl
molecul
deliv
posit
costimulatori
signal
tcell
activ
includ
pathway
exampl
molecular
pathway
deliv
neg
signal
tcell
activ
includ
ligand
delic
balanc
posit
neg
regulatori
signal
determin
outcom
specif
immun
respons
importantli
absenc
adequ
costimulatori
signal
cell
die
becom
anerg
vitro
thu
fail
initi
evect
immun
respons
vivo
therefor
manipul
costimulatori
signal
repres
import
mechan
inhibit
immuneactiv
exposur
antigen
antigenspecif
cell
prolifer
diverenti
evector
cell
sprent
surh
vast
major
evector
cell
undergo
apoptosi
immun
respons
progress
lymphocyt
surviv
becom
longliv
memori
cell
dutton
et
al
memori
cell
specif
antigen
encount
primari
immun
respons
react
rapidli
vigor
reencount
antigen
function
term
activ
requir
memori
cell
activ
lower
concentr
byrn
et
al
requir
less
costimul
kuiper
et
al
readili
secret
evector
cytokin
bird
et
al
ehler
smith
lee
et
al
naiv
tcell
counterpart
indic
state
hyperrespons
molecul
primarili
involv
cell
migrat
tissu
includ
chemokin
integrin
selectin
matrix
metalloproteinas
mmp
chemokin
constitut
larg
famili
chemoattract
peptid
regul
vast
spectrum
leukocyt
migrat
event
interact
chemokin
receptor
integrin
famili
includ
vascular
cell
adhes
intercellular
adhes
leukocyt
function
antigen
integrin
famili
also
mediat
tcell
adhes
facilit
interact
apc
well
mediat
adhes
nonhematopoiet
cell
endotheli
cell
guid
cell
trayc
lselectin
facilit
roll
leucocyt
along
surfac
endotheli
cell
function
home
receptor
target
peripher
lymphoid
organ
mmp
famili
proteinas
secret
inflammatori
cell
digest
specif
compon
extracellular
matrix
therebi
facilit
lymphocyt
entri
basement
membran
includ
bloodbrain
barrier
bbb
th
cell
play
critic
role
orchestr
immun
respons
part
product
cytokin
provid
secondari
signal
cell
immun
cascad
two
major
type
th
cell
respons
describ
cell
produc
tnf
interferon
ifn
cell
produc
cell
primarili
secret
tgfha
describ
context
oral
toler
myelin
antigen
fukaura
et
al
hafler
et
al
immunemedi
set
minguela
et
al
subset
cell
interregul
develop
cytokin
suppress
diverenti
vice
versa
fig
subset
cell
predominantli
produc
describ
yao
et
al
cell
believ
repres
distinct
subset
ifn
produc
cell
evidenc
depend
th
cell
tgffor
diverenti
bettelli
et
al
mangan
et
al
veldhoen
et
al
expans
aggarw
et
al
langrish
et
al
oppos
cell
depend
respect
diverenti
expans
cytokin
shown
suppress
develop
cell
harrington
et
al
park
et
al
intrigu
relationship
gener
pathogen
regulatori
cell
recent
demonstr
tgfi
critic
diverenti
gener
regulatori
cell
howev
addit
expos
cultur
cell
diverenti
cell
bettelli
et
al
tanuja
chitni
tradit
th
cell
subset
distinguish
pattern
cytokin
product
howev
identif
distinguish
surfac
molecul
marker
major
advanc
field
tcell
ig
mucindomaincontain
molecul
tim
repres
import
famili
molecul
encod
cellsurfac
receptor
involv
regul
immun
specif
express
cell
neg
regul
respons
interact
ligand
also
express
cell
monney
et
al
sabato
et
al
zhu
et
al
express
cell
appear
neg
regul
cell
prolifer
although
fulli
establish
express
cell
cell
interact
apc
induc
tcell
prolifer
meyer
et
al
intracellular
signal
mechan
provid
link
bind
cytokin
receptor
evect
cytokin
cellular
function
janu
kinas
signal
transduc
activ
transcript
jakstat
famili
transducertranscriptionactiv
factor
play
critic
role
signal
mani
cytokin
receptor
cytokin
bind
specif
receptor
activ
jak
molecul
associ
receptor
caus
phosphoryl
tyrosin
residu
bind
jak
molecul
receptor
facilit
bind
stat
protein
phosphoryl
receptor
subsequ
dissoci
receptor
dimer
activ
transcript
gene
contain
specif
cisregulatori
statbind
sequenc
diver
cytokin
receptor
associ
diver
jakstat
protein
receptor
associ
jacobson
et
al
receptor
associ
kaplan
et
al
takeda
et
al
fig
mice
defici
display
reduct
cytokin
product
decreas
bcell
prolifer
reduc
ige
kaplan
et
al
takeda
et
al
contrast
play
pivot
role
immun
respons
activ
interact
receptor
induc
transcript
ifn
jacobson
et
al
mice
defici
lack
ifnproduct
diverenti
kaplan
et
al
thierfeld
et
al
display
predominantli
phenotyp
kaplan
et
al
tbet
box
transcript
factor
directli
control
express
hallmark
cytokin
ifn
express
thu
facilit
cell
diverenti
szabo
et
al
transcript
factor
cmaf
enhanc
product
repres
import
step
induct
cell
ho
et
al
found
induc
diverenti
locat
upstream
cmaf
thu
repres
master
switch
develop
commit
ouyang
et
al
diverenti
independ
signal
park
et
al
howev
demonstr
signal
activ
bind
gene
promot
chen
et
al
major
regul
phosphoryl
subsequ
gener
chen
et
al
sever
popul
regulatori
suppressor
cell
describ
human
includ
regulatori
cell
baecherallan
et
al
dieckmann
et
al
leve
et
al
stephen
et
al
yagi
et
al
cell
koid
engleman
cell
bacchetta
et
al
tgf
produc
cell
kitani
et
al
roncarolo
leve
regulatori
cell
suppress
tcell
prolifer
varieti
mechan
includ
product
immunosuppress
cytokin
ttcell
interact
sever
studi
demonstr
cell
play
import
role
control
immun
tanuja
chitni
respons
multipl
sclerosi
ms
function
regulatori
cell
may
enhanc
immunomodulatori
therapi
crucian
et
al
fukaura
et
al
hafler
et
al
karaszewski
et
al
viglietta
et
al
cell
believ
play
central
role
pathogenesi
ms
section
summar
prevail
theori
pathogenesi
ms
evid
role
cell
human
ms
anim
model
diseas
much
current
understand
potenti
mechanist
role
cell
ms
come
anim
model
simul
featur
ms
experiment
autoimmun
encephalomyel
eae
inflammatori
central
nervou
system
cn
demyelin
diseas
may
induc
sever
anim
type
via
immun
myelin
protein
peptid
diseas
primarili
mediat
myelinreact
cell
precipit
inflammatori
demyelin
respons
within
cn
chitni
et
al
transfer
myelin
basic
protein
mbp
specif
tcell
clone
restrict
class
ii
ia
antigen
mhc
naiv
recipi
anim
caus
similar
inflammatori
demyelin
diseas
zamvil
et
al
eae
reproduc
mani
clinic
immunolog
aspect
ms
wide
use
studi
mechan
tcell
prime
respons
myelin
compon
bettelli
et
al
chitni
et
al
well
test
potenti
therapi
ms
aharoni
et
al
yednock
et
al
theiler
murin
encephalomyel
virusinduc
demyelin
diseas
tmevidd
model
viral
mediat
model
cn
inflammatori
demyelin
resembl
ms
induc
direct
cn
infect
neurotrop
tmev
picornaviru
initi
result
immunemedi
reaction
primarili
involv
tmevspecif
cell
clatch
et
al
rodriguez
et
al
howev
chronic
stage
diseas
tcell
reactiv
host
myelin
peptid
observ
indic
epitop
spread
occur
caus
secondari
tcell
respons
myelin
breakdown
product
result
dissemin
autoimmun
respons
summari
tcell
immunolog
relat
anim
model
ms
beyond
scope
chapter
found
elsewher
volum
altern
sourc
chitni
khouri
b
howev
select
topic
ms
illumin
anim
studi
discuss
prevail
theori
etiolog
ms
molecular
mimicri
wherebi
cell
activ
foreign
antigen
crossreact
myelin
antigen
activ
myelinreact
cell
present
blood
cerebrospin
fluid
csf
ms
patient
contrast
nonactiv
myelinreact
cell
present
blood
control
zhang
et
al
sequenc
mbp
shown
resembl
sever
viral
sequenc
case
crossreact
tcell
respons
demonstr
although
pathogen
definit
proven
caus
ms
conceiv
certain
pathogen
serv
molecular
mimic
cn
compon
play
role
activ
myelinspecif
cell
exampl
crossreact
cell
mbp
antigen
includ
human
herpesviru
tejadasimon
et
al
staphylococc
enterotoxin
antigen
coronaviru
talbot
et
al
influenza
viru
hemagglutinin
markovicples
et
al
epsteinbarr
viru
ebv
lang
et
al
proteolipid
protein
plp
share
common
sequenc
haemophilu
influenza
olson
et
al
semliki
forest
viru
sfv
peptid
mimic
epitop
myelin
oligodendrocyt
glycoprotein
mog
mokhtarian
et
al
activ
cell
thought
migrat
cn
undergo
reactiv
respons
nascent
myelin
antigen
reactiv
cell
herald
inflammatori
respons
within
cn
result
tissu
damag
releas
secondari
antigen
subsequ
tcell
reactiv
secondari
antigen
term
epitop
spread
evid
epitop
spread
demonstr
anim
model
ms
mcmahon
et
al
vanderlugt
et
al
may
play
import
role
pathogenesi
human
diseas
although
wide
accept
paradigm
ms
pathogenesi
support
evid
studi
discuss
chapter
still
remain
mani
unansw
question
includ
ident
initi
foreign
crossreact
antigen
ident
initi
selfantigen
direct
tcell
respons
natur
epitop
spread
within
cn
moreov
pauciti
cell
certain
patholog
subtyp
ms
question
whether
altern
mechan
may
predomin
subset
heterogen
diseas
focu
myelin
protein
particular
mbp
potenti
autoantigen
ms
allegretta
et
al
chou
et
al
zhang
et
al
consider
interest
develop
role
tcell
respons
mbp
moreov
ms
diseaseassoci
mhc
class
ii
allel
shown
evect
present
mbp
peptid
tcell
clone
isol
ms
patient
wucherpfennig
et
al
wucherpfennig
et
al
activ
myelinreact
cell
present
blood
csf
ms
patient
contrast
nonactiv
myelinreact
cell
present
blood
control
zhang
et
al
furthermor
mbpreactiv
cell
isol
csf
ms
patient
display
increas
express
receptor
zhang
et
al
consist
previous
activ
memori
phenotyp
ms
patient
healthi
control
cell
activ
absenc
costimul
thu
impli
previous
activ
vivo
markovicples
et
al
scholz
et
al
mbpreactiv
cell
ms
patient
found
less
respons
blockad
compar
healthi
control
oliveira
et
al
signifi
ms
patient
cell
subject
normal
regulatori
mechan
although
contribut
mbpreactiv
cell
pathogenesi
ms
current
unknown
diverenti
phenotyp
costimulatori
requir
indic
memori
potenti
dysregul
cell
popul
tcell
reactiv
myelin
protein
peptid
ms
explor
studi
examin
plp
tcell
respons
demonstr
tcell
prolifer
certain
epitop
pelfrey
et
al
diverenti
reactiv
compar
control
markovicples
et
al
zhang
et
al
tcell
respons
recombin
mog
appear
similar
ms
patient
healthi
control
diazvilloslada
et
al
although
studi
demonstr
increas
reactiv
kerlero
de
rosbo
et
al
alter
tcell
properti
van
der
aa
et
al
ms
patient
studi
examin
tcell
respons
myelin
oligodendrocyt
basic
protein
mobp
holz
et
al
cyclic
nucleotid
phosphodiesteras
cnpase
muraro
et
al
reactiv
demonstr
tcell
line
isol
select
ms
patient
tcell
reactiv
cn
antigen
fulli
explor
due
technic
diyculti
perform
interpret
result
assay
mani
studi
current
employ
strategi
expand
cell
use
nonspecif
method
mixtur
myelin
peptid
studi
patient
postinfecti
encephalomyel
acut
dissemin
encephalomyel
adem
consist
found
robust
tcell
reactiv
myelin
peptid
blood
csf
hafler
et
al
hemachudha
et
al
pohlkopp
et
al
suggest
intrigu
relationship
pathophysiolog
adem
ms
studi
examin
tcr
repertoir
ms
patient
demonstr
bia
use
chain
variabl
region
v
kotzin
et
al
lozeron
et
al
oksenberg
et
al
led
explor
tcr
v
therapi
tcr
vaccin
employ
tcr
v
peptid
role
cell
pathogenesi
thought
exert
evect
enhanc
function
regulatori
tcell
popul
recogn
tcr
determin
vandenbark
vandenbark
et
al
current
undergo
pilot
studi
ms
phase
ii
trial
use
antibodi
specif
target
v
sequenc
tcr
shown
success
signific
advers
evect
olsson
et
al
howev
group
gran
et
al
lozeron
et
al
musett
et
al
found
predomin
usag
v
chain
indic
potenti
limit
tcr
v
therapi
studi
twin
demonstr
similar
select
tcr
v
chain
concord
twin
respons
mbp
compar
discord
twin
control
suggest
genet
basi
evolut
selfantigen
tcell
respons
utz
et
al
ms
patient
treat
autolog
hematopoiet
stem
cell
transplant
demonstr
increas
naiv
compar
memori
cell
increas
tcr
divers
indic
broader
clonal
phenotyp
year
follow
therapi
muraro
et
al
separ
studi
ascertain
similar
find
found
mbpreactiv
cell
demonstr
broader
epitop
recognit
follow
reconstitut
sun
et
al
patholog
ms
lesion
character
perivascular
infiltr
cell
macrophag
prinea
wright
traugott
et
al
cell
macrophag
also
found
toward
peripheri
lesion
normal
appear
white
matter
traugott
et
al
cell
shown
predomin
acut
lesion
cell
observ
frequent
chronic
lesion
rain
similar
densiti
cell
demonstr
four
histopatholog
subtyp
ms
although
type
iii
iv
lesion
addit
character
promin
oligodendrocyt
degener
lucchinetti
et
al
attempt
isol
tcell
clone
brain
ms
patient
fail
show
either
mbp
plp
reactiv
hafler
et
al
tcr
analysi
ms
lesion
demonstr
broad
tcr
v
v
repertoir
activ
lesion
fewer
tcr
v
gene
detect
chronic
plaqu
control
sampl
wucherpfennig
et
al
studi
demonstr
restrict
tcr
specif
rearrang
v
gene
found
brain
patient
hla
posit
suggest
mhc
class
ii
genotyp
may
play
role
vdj
rearrang
ms
lesion
oksenberg
et
al
cell
parenchym
ms
lesion
lack
indic
diverenti
centralmemori
cell
evector
memori
cell
presum
restimul
antigen
within
cn
kivisakk
et
al
summari
multipl
studi
demonstr
presenc
cell
ms
lesion
argu
central
role
ms
pathogenesi
lack
tanuja
chitni
consensu
regard
tcell
specif
suggest
heterogen
tcell
respons
time
analysi
may
result
epitop
spread
chronic
diseas
costimulatori
pathway
deliv
posit
neg
signal
tcell
activ
thu
repres
import
control
step
immun
respons
famili
costimulatori
molecul
repres
import
step
activ
cell
lesion
cn
patient
ms
found
exclus
associ
express
perivenular
lymphocyt
express
macrophag
ms
neurolog
diseas
windhagen
et
al
peripher
blood
mononuclear
cell
pbmc
isol
ms
patient
show
increas
express
cell
patient
rapidli
progress
diseas
compar
stabl
diseas
normal
control
mena
rohowskykochan
separ
studi
express
local
b
cell
found
increas
ms
relaps
treatment
reduc
number
b
cell
increas
number
monocyt
genc
et
al
total
observ
suggest
pathway
activ
ms
particular
may
play
import
role
regul
diseas
activ
genet
polymorph
costimulatori
molecul
may
contribut
diseas
suscept
three
gene
polymorph
found
ms
patient
healthi
control
liger
et
al
howev
associ
found
diseas
cours
sever
masterman
et
al
olmstead
counti
studi
two
polymorph
associ
presenc
ms
kantarci
et
al
canadian
collabor
studi
found
associ
polymorph
diseas
cours
ms
dyment
et
al
exon
ag
polymorph
associ
presenc
oligoclon
band
csf
fukazawa
et
al
thu
dysregul
signal
may
contribut
suscept
ms
phase
safeti
studi
well
multicent
studi
ms
ongo
interact
apc
cell
induc
apc
product
major
factor
cell
diverenti
kelsal
et
al
express
increas
lesion
postmortem
ms
brain
compar
control
found
predominantli
macrophag
microglia
coloc
tcell
marker
gerrits
et
al
express
found
higher
peripher
blood
monocyt
isol
spm
compar
rrm
role
cell
pathogenesi
healthi
control
filion
et
al
jensen
et
al
reduc
ifntreat
teleshova
et
al
pbmc
spm
patient
produc
ifnwhen
restimul
vitro
compar
healthi
control
karni
et
al
summari
studi
indic
pathway
import
regul
cytokin
product
ms
clinic
trial
antibodi
biogen
autoimmun
diseas
itp
lupu
termin
occurr
thromboembol
event
anoth
formul
antibodi
idec
pharmaceut
investig
phase
clinic
trial
ms
patient
recent
perform
good
safeti
data
therapeut
evect
current
investig
program
express
cell
neg
regul
tcell
activ
polymorph
shown
genet
modifi
progress
ms
may
relat
inhibit
tcell
activ
kroner
et
al
tim
famili
molecul
import
cellsurfac
marker
well
costimulatori
regul
respons
ms
patient
csf
tcell
clone
demonstr
reduc
level
tbet
secret
higher
amount
ifnthan
control
subject
indic
may
repres
import
regul
respons
ms
koguchi
et
al
summari
signific
evid
costimulatori
molecul
repres
import
step
control
tcell
activ
ms
viabl
therapeut
target
context
ms
cytokin
thought
mediat
diseas
cytokin
believ
play
protect
role
howev
understand
diseas
evolv
clear
paradigm
absolut
moreov
evid
distinct
lineag
cell
led
reevalu
role
cytokin
ms
cytokin
predominantli
found
brain
ms
patient
pauciti
cytokin
particular
tgf
observ
cannel
la
rain
e
b
hofma
n
et
al
woodroof
e
cuzner
studi
use
semiquantit
rtpcr
immunocytochemistri
found
increas
express
acut
ms
plaqu
compar
sampl
isol
inflammatori
infarct
windhagen
et
al
ifn
tnfwere
express
cell
locat
perivascular
cuv
suggest
acut
ms
lesion
inflammatori
cell
import
sourc
cytokin
woodroof
cuzner
express
tnfwa
local
macrop
hage
microglia
astrocyt
es
cannel
la
rain
e
b
tanuja
chitni
hofman
et
al
selmaj
et
al
chronicact
lesion
separ
studi
found
express
predominantli
associ
perivascular
inflammatori
cell
examin
acut
ms
lesion
hofman
et
al
contrari
paradigm
ms
high
level
express
acut
chronicact
ms
lesion
obviou
correl
resolut
lesion
cannella
rain
studi
use
rn
microarra
ys
ms
brain
autopsi
found
increas
transcript
gene
encod
ifn
lock
et
al
indic
potenti
role
cell
proinflammatori
respons
ms
sever
studi
demonstr
enhanc
product
hallmark
cytokin
ifn
pbmc
restimul
ex
vivo
ms
patient
compar
control
comabella
et
al
clinic
attack
correl
increas
ifnproduct
vitro
beck
et
al
similar
studi
ifnwa
found
blunt
increas
product
ifndur
relaps
becher
et
al
tcrmediat
ifnand
secret
increas
relapsingremit
rr
secondari
progress
sp
patient
primari
progress
diseas
suggest
dysregul
signal
pathway
certain
ms
subtyp
balashov
et
al
interestingli
spm
patient
also
exhibit
season
variat
ifnproduct
increas
express
autumn
winter
month
compar
spring
summer
month
observ
normal
control
progress
cours
ms
found
significantli
frequent
carrier
allel
schrijver
et
al
administr
ifnto
ms
patient
precipit
clinic
attack
confirm
role
ifna
proinflammatori
cytokin
ms
panitch
et
al
b
studi
prototyp
cytokin
ms
limit
express
high
level
acuteand
chronicact
ms
lesion
cannella
rain
high
frequenc
tcell
clone
reactiv
mbpand
plpexpress
found
ms
patient
compar
untreat
patient
chou
et
al
increas
express
secret
pbmc
demonstr
spm
patient
treat
cyclophosphamid
methylprednisolon
compar
untreat
patient
thu
role
pathogenesi
ms
unclear
howev
may
associ
respons
therapi
studi
examin
cell
activ
ms
found
dendrit
cell
ms
patient
secret
elev
amount
express
increas
level
mrna
associ
increas
tcell
product
vaknindembinski
et
al
japanes
studi
examin
cytokin
express
found
csf
level
significantli
higher
opticospinalm
patient
convent
rrm
patient
may
associ
pronounc
neutrophil
infiltr
typic
found
opticospin
diseas
variant
ishizu
et
al
alter
function
sever
popul
regulatori
cell
demonstr
ms
induct
regulatori
antigenspecif
cell
oral
toler
myelin
protein
describ
fukaura
et
al
hafler
et
al
defici
subset
suppressor
cell
demonstr
ms
patient
crucian
et
al
moreov
increas
adrenerg
receptor
densiti
cell
found
ms
compar
control
karaszewski
et
al
much
attent
focus
subset
regulatori
cell
induct
cell
control
transcript
regul
also
serv
cellspecif
marker
hori
et
al
defect
evector
function
regulatori
cell
demonstr
ms
patient
viglietta
et
al
thu
defect
regulatori
tcell
popul
may
facilit
develop
andor
progress
autoimmun
tcell
migrat
cn
ms
believ
follow
sequenc
captur
roll
activ
adhes
strengthen
final
transmigr
bbb
specif
event
may
vari
depend
region
cn
well
activ
state
cell
microvasculatur
two
process
appear
import
tcell
migrat
cn
migrat
cell
blood
csf
interact
dendrit
element
lumin
surfac
choroid
plexu
result
immunosurveil
tcell
migrat
inflam
endotheli
bbb
interact
perivascular
apc
within
virchowrobbin
space
engelhardt
ransohov
evid
exist
process
ms
howev
rel
contribut
unclear
may
depend
stage
subtyp
diseas
adhes
molecul
express
inflam
bbb
ms
express
infiltr
cell
suggest
import
role
pathway
tcell
migrat
ms
bo
et
al
inhibit
interact
integrin
molecul
present
surfac
cell
present
endotheli
cell
bbb
shown
suppress
develop
eae
yednock
et
al
led
develop
antibodi
natalizumab
evect
reduc
ms
relaps
miller
et
al
howev
clinic
trial
natalizumab
led
sever
case
progress
multifoc
leukoencephalopathi
result
reevalu
role
drug
ms
therapeut
kleinschmidtdemast
tyler
langergould
et
al
van
assch
et
al
postul
major
chemokin
involv
trayck
cell
blood
csf
immunosurveil
normal
ms
patient
kivisakk
et
al
studi
chemokin
express
peripher
blood
cell
ms
patient
found
posit
correl
express
blood
cell
eikelenboom
et
al
csf
cell
sindern
et
al
mri
measur
diseas
activ
ms
patient
tcell
migrat
import
step
pathogenesi
ms
confirm
success
antibodi
therapi
natalizumab
howev
evect
blockad
cn
immunosurveil
produc
profound
advers
evect
evidenc
develop
pml
three
treat
patient
risk
infect
emerg
tumor
due
blockad
immunosurveil
must
balanc
therapeut
evect
util
power
therapeut
much
attent
focus
presenc
axon
damag
ms
plaqu
substrat
chronic
progress
diseas
trapp
et
al
trapp
et
al
although
mediat
axon
damag
includ
cytokin
complement
antibodi
nitric
oxid
cell
may
play
signific
role
neurodegener
neuroprotect
presenc
cell
cell
ms
lesion
correl
axon
damag
bitsch
et
al
tmev
model
ms
demyelin
axon
damag
found
cn
mhc
class
idefici
mice
infect
theiler
viru
riveraquinon
et
al
suggest
axon
damag
class
mediat
mice
also
display
defici
cell
cn
lesion
similarli
vitro
cellmedi
neurotox
depend
ifn
induc
express
mhc
class
medana
et
al
collect
studi
suggest
class
express
cn
particularli
neuron
may
enhanc
cytotox
tcell
respons
vitro
cocultur
human
fetal
neuron
cell
found
produc
apoptosi
neuron
giuliani
et
al
process
requir
physic
contact
cell
demonstr
transwel
experi
depend
mhc
protect
could
confer
block
cell
neuron
fasl
neuron
attent
focus
regulatori
role
neuron
may
play
cell
lewi
rat
model
eae
motoneuron
demonstr
engulf
lymphocyt
process
consist
emperipolesi
smith
et
al
neuron
product
tgfha
shown
play
signific
role
induct
regulatori
cell
murin
eae
model
liu
et
al
studi
import
implic
understand
cellneuron
interact
ms
although
mbpreactiv
cell
implic
pathogenesi
ms
zhang
et
al
zhang
et
al
intrigu
studi
shown
passiv
transfer
mbpreactiv
cell
result
protect
retin
ganglion
cell
bodi
optic
nerv
crush
injuri
vivo
moalem
et
al
interestingli
transfer
cell
specif
antigen
protect
furthermor
express
mrna
sever
nerv
growth
factor
includ
brainderiv
neurotroph
factor
bdnf
upregul
antigenactiv
cell
injur
nerv
express
mrna
nerv
growth
factor
receptor
moalem
et
al
two
major
type
th
cell
respons
describ
base
cytokin
secret
cell
produc
cytokin
ifnand
tnf
cell
produc
eae
associ
respons
cytokin
gener
protect
support
find
separ
studi
demonstr
presenc
myelinreact
cell
confer
neuroprotect
organotyp
hippocamp
slice
cultur
wolf
et
al
find
sever
implic
ms
first
myelinreact
cell
may
neuroprotect
certain
condit
includ
trauma
suggest
ms
brain
may
suscept
inflammationinduc
damag
second
local
product
neurotroph
factor
inflammatori
cell
may
neuroprotect
howev
contrast
find
studi
shown
mbptcr
transgen
mice
sustain
cn
damag
inflamm
follow
traumat
spinal
cord
injuri
compar
wildtyp
control
jone
et
al
tcell
infiltr
local
area
demyelin
axon
loss
suggest
autoreact
cell
trigger
autoimmun
demyelin
set
trauma
certain
circumst
therefor
therapeut
potenti
neuroprotect
lymphocyt
entertain
caution
glatiram
acet
ga
establish
treatment
rrm
mechan
action
reli
part
migrat
cell
cn
aharoni
et
al
aharoni
et
al
presum
downregul
local
inflammatori
respons
interestingli
cell
shown
produc
bdnf
eae
model
aharoni
et
al
gareact
cell
harvest
ms
patient
treat
ga
produc
bdnf
restimul
vitro
ziemssen
et
al
howev
role
bdnf
neuroprotect
ms
eae
establish
thu
role
neurotroph
factor
requir
explor
success
sever
celltarget
therapi
ms
reinforc
import
role
cell
ms
pathogenesi
six
approv
therapi
ms
evect
ga
natalizumab
directli
relat
modul
tanuja
chitni
tcell
function
modul
tcell
function
includ
tcell
migrat
cytokin
product
yong
mitoxantron
cytotox
agent
nonspecif
abrog
tand
bcell
prolifer
alter
peptid
ligand
apl
may
defin
peptid
serv
receptor
ligand
substitut
singl
multipl
amino
acid
lead
chang
function
outcom
receptor
signal
bielekova
martin
apl
commonli
use
tcr
ligand
alter
tcell
respons
presum
immunogen
target
antigen
presum
result
immun
suppress
immun
deviat
well
induct
regulatori
tcell
popul
reactiv
apl
serv
downregul
inflammatori
diseas
process
bystand
suppress
glatiram
acet
ga
copaxon
fda
approv
therapi
treatment
rrm
ga
apl
origin
develop
mimic
mbp
compos
random
sequenc
amino
acid
glutam
acid
lysin
alanin
tyrosin
present
specif
molar
ratio
copaxon
administ
daili
subcutan
inject
phase
iii
clinic
trial
found
reduc
relaps
frequenc
well
decreas
incid
new
gadolinium
enhanc
lesion
mri
ge
et
al
johnson
et
al
despit
crude
resembl
mbp
evid
sever
studi
show
ga
stimul
sever
nonmyelin
antigen
tcell
line
suggest
ga
act
univers
degener
tcell
antigen
duda
et
al
ga
shown
inhibit
respons
mbpspecif
tcell
line
vitro
rack
et
al
vivo
treatment
ga
induc
hyporespons
antigen
schmi
et
al
interestingli
gareact
tcell
line
isol
treat
patient
well
untreat
control
found
crossreact
varieti
peptid
suggest
degener
antigen
addit
cytokin
deviat
note
gareact
tcell
line
duda
et
al
eae
model
gareact
cell
shown
accumul
cn
attenu
diseas
aharoni
et
al
thu
princip
mechan
action
copaxon
may
induct
respons
exert
bystand
suppress
inflamm
within
cn
apl
target
mbp
wide
studi
ms
interest
potenti
autoantigen
apl
mbp
peptid
shown
evect
amelior
diseas
eae
model
karin
et
al
initi
phase
clinic
trial
test
four
dose
apl
mbp
administ
subcutan
week
demonstr
safeti
concern
bielekova
martin
two
phase
ii
trial
use
mbp
apl
initi
small
nihbas
trial
test
highest
dose
apl
mg
administ
weekli
month
three
eight
patient
develop
atyp
ms
exacerb
character
high
gadoliniumenhanc
lesion
load
tumefactivetyp
lesion
flaccid
paralysi
inflammatori
involv
peripher
role
cell
pathogenesi
nervou
system
exacerb
correl
enhanc
reactiv
mbp
second
larger
multicent
studi
test
three
dose
apl
mg
versu
placebo
total
patient
termin
occurr
aplinduc
system
hypersensit
reaction
enrol
patient
kappo
et
al
studi
enhanc
ex
vivo
tcell
respons
apl
observ
follow
treatment
patient
develop
hypersensit
reaction
enhanc
respons
apl
could
demonstr
kappo
et
al
phase
ii
studi
investig
evect
lowdos
apl
current
undergo
safeti
evalu
tcell
vaccin
strategi
attempt
elimin
pathogen
cell
enhanc
regulatori
immun
respons
autoreact
cell
approach
requir
isol
autoreact
tcell
clone
individu
patient
blood
csf
subcutan
reinject
form
immun
vaccin
pilot
trial
tcell
vaccin
autolog
mbpspecif
cell
peripher
blood
rrm
spm
patient
demonstr
modest
reduct
posttreat
relaps
rate
medaer
et
al
zhang
et
al
studi
frequenc
gadoliniumenhanc
lesion
larg
unchang
posttreat
second
pilot
trial
use
autolog
mbp
mogreact
tcell
vaccin
rrm
nonrespond
demonstr
signific
reduct
relaps
rate
p
well
gadolinium
enhanc
lesion
load
achiron
et
al
studi
seriou
advers
event
note
small
studi
util
myelinreact
cell
deriv
autolog
csf
advers
evect
observ
five
treat
patient
van
der
aa
et
al
larger
phase
ii
trial
use
tcell
vaccin
plan
tcr
vaccin
strategi
target
tcr
sequenc
believ
critic
immunopathogenesi
ms
ms
v
identifi
domin
tcr
variabl
region
sequenc
involv
mbp
tcell
reactiv
kotzin
et
al
lozeron
et
al
oksenberg
et
al
tcr
vaccin
thought
exert
evect
enhanc
function
regulatori
tcell
popul
recogn
tcr
determin
vandenbark
vandenbark
et
al
tcr
peptid
deriv
v
region
tcr
use
vaccin
ms
patient
doubleblind
pilot
studi
patient
treat
weekli
monthli
inject
peptid
patient
carri
allel
enhanc
tcell
respons
immun
peptid
correl
clinic
improv
bourdett
et
al
vandenbark
et
al
tcell
respons
mbp
trend
downward
respond
major
advers
event
observ
treat
patient
antibodi
specif
target
v
sequenc
tcr
result
multicent
phase
ii
studi
ms
patient
treat
runin
regimen
monthli
month
show
signific
reduct
new
gadolinium
mri
tanuja
chitni
lesion
posttreat
despit
signific
reduct
v
cell
olsson
et
al
ms
relaps
occur
three
treat
patient
howev
advers
event
directli
relat
drug
observ
neg
result
suggest
consider
variabl
v
profil
individu
ms
patient
altern
explan
time
diseas
present
clinic
epitop
spread
occur
negat
use
singl
vdeplet
agent
cellsurfac
marker
th
cell
random
phase
ii
doubleblind
trial
antibodi
administ
intraven
rrm
spm
patient
van
oosten
et
al
administr
antibodi
result
rapid
sustain
reduct
circul
cell
infusionrel
side
evect
includ
nausea
fever
tachycardia
limit
postinfus
month
treat
patient
demonstr
approxim
reduct
relaps
rate
compar
placebo
control
howev
signific
chang
number
gadoliniumenhanc
lesion
mri
although
therapi
evect
reduc
relaps
rate
lack
eycaci
primari
mri
measur
led
question
regard
evect
ms
jakstat
famili
transducertranscriptionactiv
factor
play
critic
role
signal
mani
cytokin
receptor
coenzym
hmgcoa
reductas
inhibitor
atorvastatin
shown
exert
protect
evect
eae
induct
phosphoryl
secret
cytokin
concomit
inhibit
phosphoryl
secret
cytokin
youssef
et
al
pilot
clinic
trial
simvastatin
ms
show
posit
result
larger
trial
atorvastatin
way
inhibit
molecular
pathway
involv
tcell
migrat
evect
reduc
ms
relaps
miller
et
al
howev
clinic
trial
antibodi
led
sever
case
progress
multifoc
leukoencephalopathi
result
reevalu
role
drug
ms
therapeut
kleinschmidtdemast
tyler
langergould
et
al
van
assch
et
al
conclus
summar
evid
central
role
cell
pathogenesi
ms
repres
work
mani
team
investig
mani
year
although
much
progress
made
field
led
import
therapeut
advanc
sever
question
remain
unansw
includ
natur
initi
tcell
respons
role
cell
pathogenesi
mechan
propag
diseas
within
cn
field
tcell
biolog
remain
integr
part
ms
question
advanc
undoubtedli
lead
improv
treatment
strategi
patient
